Literature DB >> 21068760

Andrology: Identifying late-onset hypogonadism in older men.

T Hugh Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21068760     DOI： 10.1038/nrurol.2010.162

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

1.  Identification of late-onset hypogonadism in middle-aged and elderly men.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Jennifer M Beynon; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Steven Boonen; Dirk Vanderschueren; Fernand Labrie; Ilpo T Huhtaniemi
Journal:  N Engl J Med       Date:  2010-06-16       Impact factor: 91.245

2.  Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations.

Authors:  C Wang; E Nieschlag; R Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; I M Thompson; W Weidner; F C W Wu
Journal:  J Androl       Date:  2008-09-04

3.  Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes.

Authors:  R D Stanworth; D Kapoor; K S Channer; T H Jones
Journal:  Eur J Endocrinol       Date:  2008-09-19       Impact factor: 6.664

Review 4.  Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

Authors:  Shalender Bhasin; Glenn R Cunningham; Frances J Hayes; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2010-06       Impact factor: 5.958

5.  Association of specific symptoms and metabolic risks with serum testosterone in older men.

Authors:  Michael Zitzmann; Stephanie Faber; Eberhard Nieschlag
Journal:  J Clin Endocrinol Metab       Date:  2006-08-22       Impact factor: 5.958

6.  Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe Casanueva; Gianni Forti; Aleksander Giwercman; Ilpo T Huhtaniemi; Krzysztof Kula; Margus Punab; Steven Boonen; Dirk Vanderschueren
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

7.  Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.

Authors:  Dheeraj Kapoor; Hazel Aldred; Stephanie Clark; Kevin S Channer; T Hugh Jones
Journal:  Diabetes Care       Date:  2007-04       Impact factor: 19.112

8.  Prevalence of symptomatic androgen deficiency in men.

Authors:  Andre B Araujo; Gretchen R Esche; Varant Kupelian; Amy B O'Donnell; Thomas G Travison; Rachel E Williams; Richard V Clark; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2007-08-14       Impact factor: 5.958

Review 9.  Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men.

Authors:  Michael Zitzmann
Journal:  Nat Clin Pract Urol       Date:  2007-03
  9 in total
  1 in total

1.  Applying machine learning techniques to the identification of late-onset hypogonadism in elderly men.

Authors:  Ti Lu; Ya-Han Hu; Chih-Fong Tsai; Shih-Ping Liu; Pei-Ling Chen
Journal:  Springerplus       Date:  2016-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.